ProKidney Pharma (PROK): Bathi resik saben saham (EPS TTM)

PROK (ProKidney Corp.) - tandha merek perusahaan

ProKidney Corp. (PROK) is developing a unique cell therapy for kidney regeneration, where success depends on FDA approval. The annual earnings per share trend reflects the current state of the business, with the parameter stabilizing at -0.55. While a personalized approach to treatment is establishing a new standard in nephrology, the lack of ready-made products temporarily deprives the company of pricing power.

PROK Bathi saben saham sajrone 12 wulan pungkasan ProKidney Pharma (28.04.2023 - 13.11.2026)

Rincian analitis lan laporan data perusahaan ProKidney Corp (PROK)

- rega saham lan target rega konsensus:
Rega saham ProKidney Corp.|PROK - Target median analis
- data kapitalisasi bursa:
Kapitalisasi pasar ProKidney Corp.|PROK - Nilai Bisnis
- rincian valuasi buku bisnis:
Aset Bersih saben Siji Saham ProKidney|PROK - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku prokidney.com|PROK - Aset Perusahaan
- indikator beban utang lan likuiditas:
Rasio Total Utang marang Ekuitas ProKidney Corp.|PROK - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas ProKidney Inc.|PROK - Gunggung tanggungan utang perusahaan|Rasio utang marang kapitalisasi buku ProKidney Corp.|PROK - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan ProKidney|Likuiditas cepet prokidney.com
- data bathi lan kelipatan valuasi:
PROK - Bathi resik|Proyeksi bathi mangsa ngarep ProKidney Corp.|PROK - Periode bali modal bisnis|Pangali Forward P/E ProKidney|PROK - Rasio P/E diaturake wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan ProKidney Corp.|PROK - Bathi operasional sadurunge amortisasi|Bathi resik saben saham (EPS TTM) ProKidney|PROK - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan prokidney.com|PROK - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep ProKidney Corp.
Ringkesan analisis perusahaan:PROK - ProKidney Corp.
Barang unggulan ProKidney Inc.

Trailing twelve-month earnings per share (EPS TTM) reflects the actual efficiency of capital generation per share of the business, isolating the financial result from the impact of the total number of securities. By analyzing the current annual earnings per share, an investor assesses the ability of ProKidney Corp. (PROK) to fund the development of cell therapy for kidney restoration without excessive equity dilution.

Perusahaan pesaing

Travere Therapeutics - Bathi resik saben saham (EPS TTM)|Bathi resik saben saham sajrone patang kuartal pungkasan ardelyx.com ARDX|AKBA: Bathi resik saben saham (EPS TTM)|Bathi saben saham sajrone 12 wulan pungkasan TVRD|Bathi saben saham sajrone rolas wulan pungkasan DiaMedica Pharma|Bathi saben saham sajrone 12 wulan pungkasan UNCY (Unicycive Therapeutics, Inc)|Bathi resik saben saham (EPS TTM) RMTI|CVKD - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Conduit Pharmaceuticals Inc. - Bathi resik saben saham sajrone 12 wulan pungkasan|Calliditas Therapeutics, Inc. (CALT) - Bathi resik saben siji saham sajrone rolas wulan pungkasan|RNLX - Bathi saben saham sajrone rolas wulan pungkasan|Bathi saben siji saham sajrone 12 wulan pungkasan ZVSA